RMD

ResMed
D

RMD

243.530
USD
1.95
(0.81%)
Market Closed
Volume
0
EPS
7
Div Yield
0.83
P/E
35
Market Cap
35,782,378,940
Related Instruments
    ABT
    ABT
    0.850
    (0.74%)
    117.25 USD
    B
    BAX
    0.260
    (0.82%)
    31.970 USD
    BDX
    BDX
    -2.040
    (-0.90%)
    225.190 USD
    BSX
    BSX
    -0.590
    (-0.67%)
    87.000 USD
    EW
    EW
    1.620
    (2.45%)
    67.780 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    155.48 USD
    MDT
    MDT
    1.520
    (1.77%)
    84.75 USD
    P
    PRGO
    -0.140
    (-0.52%)
    26.800 USD
    SYK
    SYK
    6.90
    (1.80%)
    390.14 USD
    Z
    ZBH
    3.638
    (3.34%)
    112.490 USD
    More
News

Title: ResMed

Sector: Healthcare
Industry: Medical Instruments & Supplies
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.